-
-
-
-
-
-
-
pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasertâ„¢ Three-Year Treatment for Posterior Segment Uveitis
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

